We recently reported a novel, heterozygous, and non-synonymous ACTC1 mutation (p.Gly247Asp or G247D) in a large, multigenerational family, causing atrial-septal defect followed by lateonset dilated cardiomyopathy (DCM). We also found that the G247D ACTC1 mutation negatively regulated serum response (SRF)-signaling thereby contributing to the late-onset DCM observed in human patients carrying this mutation ("A cardiac aactin (ACTC1) p. Gly247Asp mutation inhibits SRF-signaling in vitro in neonatal rat cardiomyocytes" [1] ). There are some ACTC1 mutations known to date, majority of which, though, have not been investigated for their functional consequence. We thus aimed at determining the functional impact of various ACTC1 gene mutations on SRF-signaling using SM22-response element driven firefly luciferase activity assays in C2C12 cells.
Data description
Cardiac a-actin is a fundamental structural protein necessary for the maintenance of myofibrillar integrity of the heart by forming thin filaments with tropomyosin and three troponins (C, I, and T). Several isolated ACTC1 mutations have been reported till date ( Fig. 1 ) causing atrial-septal-defect, dilated and hypertrophic cardiomyopathy ( Table 1 ). Majority of these ACTC1 mutants though have not been investigated for their functional consequence. Based on our findings from G247D mutation on SRF-signaling [1] , we aimed here at deciphering the functional impact of ACTC1 genetic mutations Specifications Table   Subject Cardiology and Cardiovascular Medicine Specific subject area Molecular cardiology (molecular mechanisms of dilated cardiomyopathy) Type of data Table  Graph  Figure  How data were acquired Chemiluminescence was measured photometrically on an Infinite M200 PRO system (Tecan).
Data format
Analysed Parameters for data collection ACTC1 gene mutations mentioned in Table 1 were inducted by site directed mutagenesis and used to perform the luciferase activity. Data from all the mutant genes is compared with the wild-type ACTC1 to determine the functional impact of respective mutations. Description of data collection C2C12 cells were transfected with either wild-type or one of the mutant ACTC1 together with Renilla-luciferase and Firefly-luciferase. Media was changed post 6 h transfections and cells were further incubated for 48 h. Cells were then washed twice with PBS, lysed with the active lysis buffer and the assay was performed using dual luciferase reporter assay kit (Promega), according to the manufacturer's instructions. Bioluminescence was measured photometrically on an Infinite M200 PRO system (Tecan 
Value of the Data
Present data is a preliminary evidence of the differential functional impact ACTC1 genetic mutations on SRF-signaling These data provide a basis molecular cardiologists working on ACTC1 for further evaluation of these ACTC1 mutations for genotype-phenotype correlations Functional differences obtained here highlight the fact that different localizations of known or yet to be identified ACTC1 mutations affect the tertiary structure thereby affecting protein-protein interactions, which needs to be experimentally validated. on SRF-signaling using SM22-response element driven Firefly luciferase activity assay in C2C12 cells. The data is shown in Fig. 2 and the respective raw and analysed data is provided in a separate excel file. 
Experimental design, materials, and methods

Cloning of wild-type and mutant ACTC1
Wild-type human ACTC1 gene was cloned into PDONR221 using Gateway technology (BP clonase II reaction, Life technologies) and subsequently recombined into mammalian expression vector pDEST47 (LR clonase II reaction, Life technologies). Site-directed mutagenesis for ACTC1 single nucleotide variants was performed using QuikChange XL Kit (Stratagene) according to manufacturer's instructions. All the constructs were verified by Sangers sequencing to confirm the ACTC1 genotypes.
Luciferase reporter gene assay
C2C12 cells at the confluency of approximately 50% in 12xwell plates were transfected with either wild-type or one of the mutant ACTC1 plasmids together with SM22-promoter driven Firefly-luciferase construct as well as Renilla luciferase under the control of a thymidine kinase promoter (pRLTK) to normalize for transfection efficiency. Media was changed post 6 h transfections and cells were further incubated for 48 h. Cells were then washed twice with PBS, lysed with 150 ml of the active lysis buffer by shaking the plates on a horizontal plate shaker for 20 min. Luciferase assay was performed with 20 ml of the lysates using dual luciferase reporter assay kit according to the manufacturer's instructions (Promega) in 96-well luminometry plates. Bioluminescence was measured photometrically on an Infinite M200 PRO system (Tecan). All the experiments were performed in hexaplicate and repeated two times.
